Skip to content
Catalyst

Silybum marianumFinding

Silybum marianum decreases C-reactive protein concentration

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“There was a significant reduction in hs-CRP levels by 26.83% (p < 0.05) in the silymarin group compared to the placebo group.”
Quoted verbatim from Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
This finding among the 123 findings on its endpoint

Silybum marianum

C-reactive protein concentration

lowers

Who
adults aged 25-50 with type 2 diabetes mellitus on stable medication; fasting blood samples
Dose studied
140 mg dried Silybum marianum extract three times daily for 45 days

Very limited evidencePMID 25765835 · 2015

02 · The study

Study
RCT
Duration
6 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FQ39X12JWRFTVX6HHJENJJ